Leukemia vs Lymphoma Framework

Leukemia vs lymphoma trips up students because both involve WBC malignancies, but the framework is different: leukemia = primarily blood and bone marrow involvement, lymphoma = primarily lymph node/tissue involvement. For USMLE Step 1, the most common wrong answer on this overview topic is diagnosing acute leukemia from any elevated blast count — the WHO threshold is 20% or more, and a marrow with 12-15% blasts means MDS or another myeloid neoplasm, not AML. That said, the CLL/SLL line blurs — same disease, just staged differently. You need to know the blast threshold, the age distribution for each major leukemia, and the acute vs. chronic mechanistic distinction. The exam tests this as recall (what's the most common leukemia in children?) and as application (a bone marrow biopsy shows 15% blasts — what's the diagnosis?).

The acute vs chronic distinction is not just about speed of onset — it's mechanistic. Acute leukemias are defined by a block in differentiation: blasts pile up because they can't mature. Chronic leukemias involve cells that can differentiate but proliferate excessively. This is why chronic leukemias often present with high WBC counts of recognizable mature cells, while acute leukemias present with blasts. USMLE Step 1 will give you a peripheral smear or bone marrow description and expect you to classify the disease correctly.

The two most tested misconceptions here are: (1) thinking any elevated blast count means acute leukemia — wrong, the WHO threshold is ≥20%; below that, think MDS or another myeloid neoplasm. And (2) placing ALL in adults — ALL is a pediatric disease peaking at age 2–5. Adults get CLL most commonly overall, and AML is the most common acute leukemia in adults. Keeping these age and threshold anchors straight is what separates a correct answer from a trap.